Supernus Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	2,680	2,856	2,016	1,584	1,935	1,553
Market Cap Growth	51.78%	41.67%	27.28%	-18.16%	24.62%	16.75%
Enterprise Value	2,337	2,577	1,589	1,362	1,912	1,634
Last Close Price	46.18	49.70	36.16	28.94	35.67	29.16
PE Ratio	-	-	27.39	1447.00	34.30	29.76
Forward PE	17.56	19.33	19.65	15.34	30.84	15.73
PEG Ratio	0.64	1.11	1.11	1.11	1.11	1.11
PS Ratio	3.45	3.97	3.05	2.61	2.90	2.68
PB Ratio	2.49	2.69	1.95	1.72	2.18	1.90
P/TBV Ratio	2.45	2.64	1.95	1.74	2.48	1.94
P/FCF Ratio	32.59	62.09	11.77	14.33	16.62	12.42
P/OCF Ratio	32.19	60.33	11.72	14.26	16.57	12.22
EV/Sales Ratio	3.01	3.58	2.40	2.24	2.87	2.82
EV/EBITDA Ratio	19.06	88.02	9.81	17.11	14.52	13.77
EV/EBIT Ratio	92.31	-	19.46	-	41.45	18.99
EV/FCF Ratio	28.41	56.04	9.28	12.32	16.42	13.06
Debt / Equity Ratio	0.03	0.03	0.03	0.04	0.49	0.52
Debt / EBITDA Ratio	0.82	1.04	0.17	0.42	3.33	3.55
Debt / FCF Ratio	0.37	0.66	0.16	0.30	3.76	3.36
Net Debt / Equity Ratio	-0.33	-0.26	-0.41	-0.24	-0.03	0.10
Net Debt / EBITDA Ratio	-9.58	-9.51	-2.63	-2.78	-0.18	0.68
Net Debt / FCF Ratio	-4.30	-6.05	-2.49	-2.01	-0.20	0.65
Asset Turnover	0.53	0.51	0.50	0.41	0.39	0.36
Inventory Turnover	0.97	1.09	1.18	0.99	0.98	1.12
Quick Ratio	1.51	1.47	2.04	1.38	0.91	1.55
Current Ratio	1.96	1.90	2.35	1.70	1.07	1.91
Return on Equity (ROE)	-2.71%	-3.68%	7.55%	0.15%	7.13%	6.85%
Return on Assets (ROA)	-2.41%	-3.47%	4.66%	-0.17%	2.72%	3.93%
Return on Invested Capital (ROIC)	-4.19%	-6.34%	8.45%	-0.28%	4.41%	6.36%
Return on Capital Employed (ROCE)	-5.39%	-5.69%	7.92%	-0.53%	3.86%	6.54%
Earnings Yield	-	-	3.65%	0.07%	2.92%	3.36%
FCF Yield	3.07%	1.61%	8.49%	6.98%	6.02%	8.05%
Buyback Yield / Dilution	-1.57%	-0.88%	-0.81%	10.01%	-13.47%	-1.24%
Total Shareholder Return	-1.57%	-0.88%	-0.81%	10.01%	-13.47%	-1.24%

SEC Filings: 10-K · 10-Q